Serrano J
Published Article JCD Selective photothermolysis with a novel 1726 nm laser beam:
In some embodiments, a pulsed release profile is achieved by solubilizing up to 40% of the delivered dose of the therapeutic agent (e.g., micronized therapeutic agent, or free base or salt or prodrug thereof
This analog has been widely applied in locally advanced or metastatic breast cancer
Management of ME/CFS As well as there being insufficient diagnostic testing available for ME/CFS patients, there are also no effective therapies (60, 488, 529531) and few established non-pharmacological treatments for ME/CFS (60), paucity of diagnostic tools (60), heterogeneity between patients (60, 529), disbelief from health care workers (60), unpredictable relapses, and multiplicity of symptoms have made it difficult to formulate a treatment for ME/CFS